Traws Pharma, Inc. Other Current Liabilities
Traws Pharma, Inc. (TRAW) had Other Current Liabilities of $88.00 thousand as of 2017-03-31, per its 10-Q filed 2017-05-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2018-03-16
- 2017-03-31: Other Liabilities, Current $88.00K.
- 2016-12-31: Other Liabilities, Current $198.00K.
- 2016-09-30: Other Liabilities, Current $243.00K.
- 2016-06-30: Other Liabilities, Current $155.00K.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2017-03-31 | $88.00K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $198.00K 10-K · filed 2018-03-16 | |
| 2016-09-30 | $243.00K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $155.00K 10-Q · filed 2016-08-15 | |
| 2015-12-31 | $6.00K 10-K · filed 2017-03-29 | |
| 2014-12-31 | $23.00K 10-K · filed 2016-03-28 | $5.00K 10-K · filed 2015-03-30 |
| 2014-09-30 | $59.00K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $124.00K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $67.00K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $74.00K 10-K · filed 2015-03-30 | $384.00K 10-K · filed 2014-03-20 |
| 2013-09-30 | $354.00K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $548.00K 10-Q · filed 2013-09-06 | |
| 2012-12-31 | $157.00K 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |